GlobalData says more adults with type 2 diabetes in England hit blood sugar and weight targets on tirzepatide than on ...

Arrowhead says its RNAi drug crossed the blood-brain barrier in healthy volunteers and sharply lowered tau, a protein tied to Alzheimer’s.

Indianapolis-based Carnyx says its oral drug boosted NREM sleep in aged animals, and it has hired Chris Brearley as chief ...

Berlin keynote details Eos SENOLYTIX's pre-clinical results with mitochondrial-targeted geropeptide on healthspan and lifespan.

INmune Bio is pairing a quantum machine with AI to find diseases beyond Alzheimer’s that its drug candidate might help.

KAUST and Oxford researchers used a transistor-based sensor to read three forms of alpha-synuclein, reaching 90.9% accuracy ...

Cognition Therapeutics wins a US patent on a new crystal form of zervimesine and has an FDA meeting on its Lewy body trial ...

A new review argues postpartum recovery may shape lifelong aging; a fandom health standard asks who helps mothers get there.

As pharma shops for de-risked science, venture money is moving later and concentrating in fewer, bigger bets – our report ...

Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for ...

TimePie's Hebe Chen spotlights key developments from Shanghai, from therapeutic targets to China’s expanding clinical ...

As its CEO takes the stage in Berlin, the company opens a window on its longest-lived treated mice – and the data behind them ...